Stanford Medicine researchers developed CRISPR-GPT, an artificial intelligence copilot designed to assist gene-editing experiment design and execution. By integrating AI into CRISPR workflows, this tool reduces complexity barriers and streamlines genomic editing processes. This novel assistant democratizes access to gene editing capability, potentially accelerating therapeutic developments and improving experimental success rates in gene therapy research.